PuSH - Publication Server of Helmholtz Zentrum München

172 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
121.
Jacobs, S.* et al.: Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam study. Am. J. Clin. Nutr. 100, 891-900 (2014)
122.
Ketterer, C. et al.: Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action. Obesity 22, 925-931 (2014)
123.
Kullmann, S. et al.: Resting-state functional connectivity of the human hypothalamus. Hum. Brain Mapp. 35, 6088-6096 (2014)
124.
Linder, K. et al.: Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity 13, 733-748 (2014)
125.
Linder, K. et al.: Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity. Diabetologia 57, 1192-1198 (2014)
126.
Linder, K. et al.: Fetal brain activity and maternal metabolism. Reprod. Sci. 21, 373A (2014)
127.
Lutz, S.Z. et al.: Common genetic variation in the human CTF1 locus, encoding cardiotrophin-1, determines insulin sensitivity. PLoS ONE 9:e100391 (2014)
128.
Lutz, S.Z.* ; Staiger, H. ; Fritsche, A. & Häring, H.-U.: Antihyperglycaemic therapies and cancer risk. Diab. Vasc. Dis. Res. 11, 371-389 (2014)
129.
Peter, A. et al.: Lower plasma creatinine and urine albumin in individuals at increased risk of type 2 diabetes with factor v leiden mutation. ISRN Endocrinol. 2014:530830 (2014)
130.
Peter, A. et al.: The hepatokine betatrophin is increased in nonalcoholic fatty liver disease and may affect insulin secretion in prediabetes. Diabetologia 57, S294 (2014)
131.
Silbernagel, G.* ; Machann, J. ; Häring, H.-U. ; Fritsche, A. & Peter, A.*: Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets. Eur. J. Clin. Nutr. 68, 97-100 (2014)
132.
Stefan, N. et al.: Impact of the adipokine adiponectin and the hepatokine fetuin-a on the development of type 2 diabetes: Prospective cohort- and cross-sectional phenotyping studies. PLoS ONE 9:e92238 (2014)
133.
Synofzik, M.* et al.: Absence of BiP co-chaperone DNAJC3 causes diabetes mellitus and multisystemic neurodegeneration. Am. J. Hum. Genet. 95, 689-697 (2014)
134.
Veit, R.* et al.: Reduced cortical thickness associated with visceral fat and BMI. Neuroimage: Clin. 6, 307-311 (2014)
135.
Wagner, R.* et al.: Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans. Acta Diabetol. 51, 71-78 (2014)
136.
Wagner, R.* et al.: Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1. Mol. Metab. 3, 261-267 (2014)
137.
Wagner, R. et al.: Clinical and non-targeted metabolomic profiling of homozygous carriers of transcription factor 7-like 2 variant rs7903146. Sci. Rep. 4:5296 (2014)
138.
Wagner, R. et al.: Peroxisome Proliferator-Activated Receptor Gamma (PPARG) modulates Free Fatty Acid Receptor 1 (FFAR1) dependent insulin secretion in humans. Mol. Metab. 3, 676-680 (2014)
139.
Wagner, R.* ; Häring, H.-U. & Fritsche, A.: Phänotypen des Prädiabetes und des Typ-2-Diabetes. Dtsch. Med. Wochenschr. 139, 1109-1113 (2014)
140.
Frank, S.* et al.: Long-term stabilization effects of leptin on brain functions in a leptin-deficient patient. PLoS ONE 8:e65893 (2013)